Precision Mental Health: Develop Tools to Inform Treatment Selection in Depression (UG3/UH3)

The purpose of this grant is to create a pipeline to accelerate the development and early validation of predictive tools and/or biomarkers to inform individual-level treatment selection among two or more existing therapeutics for depression. This phased inter-agency program will be milestone-based and provide support from multi-disciplinary teams to address scientific, technical, clinical, regulatory, and commercialization requirements.

Funding: UG3 $500,000 per year; UH3 $1,500,000 per year

Duration: 5 years total

Research Authority due date: 10 days prior to submission

LOI (encouraged) due date: 18.9.23, 18.9.23

Full proposal due date: 18.10.23, 18.10.24